Skip to content
Search

Latest Stories

Well Pharmacy urges older people and immunosuppressed patients to get their Covid boosters

Well Pharmacy is urging those eligible to take up the offer of a further Covid booster jab this spring.

Adults aged 75 years and over and anyone over 5 years old and are immunosuppressed – such as those who are undergoing chemotherapy or have had an organ transplant – are entitled to have a further Covid booster jab from mid-April, said one of the UK’s largest community pharmacy chains.


Taking part in the vaccination programme again, Well Pharmacy is encouraging people to book another booster as soon as they are contacted by the NHS – which should be at least six months after their previous booster.

The national booking site for those eligible opens this week.

The jabs have been updated since the vaccines were introduced to now target newer strains of Covid-19, Well said in a press release issued on Wednesday, 5 April.

Thousands of people are still testing positive for Covid each week according to Government data, and – while hospitalisations are down – a large number of people are still being hospitalised with Covid, so getting jabbed is as important as ever.

And the Joint Committee on Vaccination and Immunisation (JCVI) recently confirmed that hospital admissions last autumn highlighted that the risk of becoming seriously ill from coronavirus was noticeably higher in people over 75.

George Sandhu, deputy superintendent pharmacist at Well Pharmacy, said: “While – happily – we are in a very different place nationally to where we once were on Covid, it hasn’t gone away.

“Thousands of people are still testing positive each week, so if you’re at greater risk of getting poorly as a result of catching Covid then it’s important to give yourself as much protection as possible. With the ever-changing covid situation, we would highly recommend people don’t delay in getting their booster. It is the best and safest way of protecting yourself and your loved ones, with the jab protecting against different variants of the virus."

Calling on those interested, he added: “Make sure you book your appointment as soon as you are contacted by the NHS, either online or by calling 119. We hope to see some of you in our pharmacies soon. If you have any questions, our pharmacy teams will be more than happy to assist you.”

More For You

PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less
Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less
AstraZeneca partners with CEPI to develop multi-specific influenza antibody

AstraZeneca-CEPI collaboration aims to increase global access to antibody-based interventions

Getty Images

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

AstraZeneca has joined forces with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an innovative antibody technology that could help tackle future infectious disease outbreaks and pandemics swiftly and more affordably.

CEPI will provide up to US$43.5 million (£33.6 million) in funding to support the biopharmaceutical company in evaluating a type of antibody, known as a VHH (Variable Heavy domain of a Heavy chain -only antibody), through preclinical proof-of-concept studies and Phase 1 clinical trials.

Keep ReadingShow less
Community Pharmacy Patient Safety Group announces new vice-chair

Martin Sadr-Kazemi 's appointment follows the passing of Dr. José Moss in January 2025.

Martin Sadr-Kazemi appointed vice-chair of Community Pharmacy Patient Safety Group

The Community Pharmacy Patient Safety Group (CPPSG) has announced the appointment of Martin Sadr-Kazemi as its new vice-chair.

Martin, currently the medication safety officer and deputy superintendent pharmacist at Rowlands Pharmacy, has been an integral member of the CPPSG since its formation a decade ago, actively contributing to various initiatives.

Keep ReadingShow less